Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/RVX stock hub

TSX/RVX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/RVXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.7M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/RVX

In the news

Latest news · TSX/RVX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/RVX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

USD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	19
Employees Change	-3%
Employees Change Percent	-13.64
Enterprise value	CAD 149.3M
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA76128M1086
Last refreshed	2026-05-10
Market cap	CAD 31.7M
Price	CAD 0.1
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsx/RVX
Website	https://www.resverlogix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.63%
EV Earnings	-14.02x
EV/FCF	-29.67x
FCF yield	-15.89%
P/B ratio	-0.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -10.6M
Net Income Growth Years	0%
Profit Per Employee	CAD -560,499
ROA	-40.13
Roa5y	-60.17
ROCE	13.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-23.2%
Cagr15y	-18.16%
Cagr1y	122.34%
Cagr20y	-19.5%
Cagr3y	-12.64%
Cagr5y	-35.56%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 10.9M
Cash	CAD 148,081
Current Assets	CAD 2.2M
Current Liabilities	CAD 60.2M
Debt	CAD 117.8M
Debt FCF	CAD -23.41
Equity	CAD -122M
Interest Coverage	-1.17
Liabilities	CAD 132.9M
Long Term Assets	CAD 8.7M
Long Term Liabilities	CAD 72.6M
Net Cash	CAD -117.6M
Net Cash By Market Cap	CAD -371
Tangible Book Value	CAD -125.5M
Tangible Book Value Per Share	CAD -0.44
WACC	5.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.04
Net Working Capital	CAD -12M
Quick ratio	0.02
Working Capital	CAD -58.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.86%
1Y total return	122.22%
200-day SMA	0.11
3Y total return	-33.33%
50-day SMA	0.11
50-day SMA vs 200-day SMA	50over200
5Y total return	-88.89%
All Time High	29.5
All Time High Change	-99.66%
All Time High Date	2007-02-26
All Time Low	0.04
All Time Low Change	185.71%
All Time Low Date	2025-04-21
ATR	0
Beta	1.04
Beta1y	0.45
Beta2y	0.6
High	0.1
High52	0.3
High52 Date	2025-07-23
High52ch	-66.67%
Low	0.1
Low52	0.04
Low52 Date	2025-06-27
Low52ch	185.71%
Ma50ch	-7.58%
Price vs 200-day SMA	-5.66%
RSI	47.33
RSI Monthly	47.23
RSI Weekly	48.47
Sharpe ratio	1.2x
Sortino ratio	2.16
Total Return	-3.08%
Tr15y	-95.05%
Tr1m	5.26%
Tr3m	-4.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -6.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	223,611,657%
Net Borrowing	5,901,554.9
Shares Insiders	2.46%
Shares Out	316,677,576
Shares Qo Q	0.43%
Shares Yo Y	3.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -5.7M
Average Volume	17,267.5x
Bv Per Share	-0.42
CAPEX	CAD -12,340
Ch10y	-92.86
Ch15y	-95.05
Ch1m	5.26
Ch1y	122.2
Ch20y	-98.69
Ch3m	-4.76
Ch3y	-33.33
Ch5y	-88.89
Ch6m	5.26
Change	0%
Change From Open	0
Close	0.1
Days Gap	0
Depreciation Amortization	587,831.5
Dollar Volume	1,950.4
Earnings Date	2026-05-12
EBIT	CAD -6.7M
EBITDA	CAD -6.1M
EPS	CAD -0.04
F Score	2
FCF	CAD -5M
FCF EV Yield	-3.37x
FCF Per Share	CAD -0.02
Financing CF	5,919,125
Fiscal Year End	December
Income Tax	CAD 15,082
Investing CF	-889,857
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Ma150	0.11
Ma150ch	-4.76%
Ma20	0.1
Ma20ch	-1.48%
Net CF	12,340
Next Earnings Date	2026-05-12
Open	0.1
Ppne	12,303.5
Price Date	2026-05-08
Relative Volume	1.19x
Share Based Comp	641,684
Tr20y	-98.69%
Tr6m	5.26%
Volume	19,504

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/RVX pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/RVX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/RVX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.1%

Negative means the company is buying back shares.

Technical

TSX/RVX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-5.7%

50/200-day relationship not available

Beta (5Y)

1.04

Moves roughly with the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/RVX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/RVX stock rating?

tsx/RVX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/RVX analysis?

The full report lives at /stocks/tsx/RVX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/RVX?

The latest report frames tsx/RVX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/RVX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.